A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D

American Journal of Gastroenterology

Volumn 111, Issue 12, 2016, Pages 1824-1832

  Eswaran, Shanti L ^a   Chey, William D ^a   Han Markey, Theresa ^a   Ball, Sarah ^a   Jackson, Kenya ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBOHYDRATE; DISACCHARIDE; FAT; FRUCTOSE; LACTOSE; MONOSACCHARIDE; OLIGOSACCHARIDE; PECTIN; POLYOL; PROTEIN; SORBITOL; SUCROSE; SUGAR; POLYMER;

ABDOMINAL PAIN; ABNORMAL FECES COMPOSITION; ADULT; ADVERSE OUTCOME; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOATING; BRISTOL STOOL FORM SCALE; CARBOHYDRATE INTAKE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEFECATION URGENCY; DEMOGRAPHY; DIARRHEA; DIET THERAPY; DIETARY FIBER; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; FAT INTAKE; FECES COMPOSITION; FEMALE; FERMENTED PRODUCT; FOLLOW UP; HUMAN; INTERVENTION STUDY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NUTRIENT LOADING; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT DROPOUT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN INTAKE; SYMPTOM; SYMPTOM ASSESSMENT; TREATMENT RESPONSE; UNITED STATES; COMPLICATION; FERMENTATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; YOUNG ADULT;

ABDOMINAL PAIN; ADULT; AGED; DIARRHEA; DISACCHARIDES; FEMALE; FERMENTATION; FRUCTOSE; HUMANS; IRRITABLE BOWEL SYNDROME; LACTOSE; MALE; MIDDLE AGED; MONOSACCHARIDES; OLIGOSACCHARIDES; POLYMERS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84991030424     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.434     Document Type: Article

References (31)

1. Drossman DA. Th e functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90.
2. Longstreth GF, Th ompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
3. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Th er 2004; 20 Suppl 7: 31-9.
4. Maxion-Bergemann S, Th ielecke F, Abel F et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006; 24: 21-37.
5. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. Jama 2015; 313: 949-58.
6. Chey WD, Olden K, Carter E et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002; 97: 2803-11.
7. Halpert A, Dalton CB, Palsson O et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007; 102: 1972-82.
8. Eswaran S, Tack J, Chey WD. Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am 2011; 40: 141-62.
9. Bentley SJ, Pearson DJ, Rix KJ. Food hypersensitivity in irritable bowel syndrome. Lancet 1983; 2: 295-7.
10. Petitpierre M, Gumowski P, Girard JP. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy 1985; 54: 538-40.
11. Zwetchkenbaum JF, Burakoff R. Food allergy and the irritable bowel syndrome. Am J Gastroenterol 1988; 83: 901-4.
12. Barrett JS, Gearry RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Th er 2010; 31: 874-82.
13. Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366-73.
14. Halmos EP, Christophersen CT, Bird AR et al. Diets that diff er in their FODMAP content alter the colonic luminal microenvironment. Gut 2014; 64: 93-100.
15. Halmos EP, Power VA, Shepherd SJ et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146: 67-75 e65.
16. Staudacher HM, Whelan K, Irving PM et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011; 24: 487-95.
17. Mazzawi T, Hausken T, Gundersen D et al. Eff ects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Molec Med Rep 2013; 8: 845-52.
18. McIntosh K, Reed DE, Schneider T et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut; e-pub ahead of print 14 March 2016.
19. Bohn L, Storsrud S, Liljebo T et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015; 149: 1399-407.
20. Shepherd S, Gibson PR. Th e complete low-FODMAP diet: a revolutionary plan for managing IBS and other digestive disorders. Th e Experiment: New York, NY, 2013.
21. Crawford PB, Obarzanek E, Morrison J et al. Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9-and 10-year-old girls. J. Am Diet Assoc 1994; 94: 626-30.
22. Menees S, Maneerattanaporn M, Chey W. Effi cacy of rifaximin in patients with irritable bowel syndrome: a meta-analysis. Gastroenterology 2011; 140: S49-50.
23. Camilleri M, Chey WY, Mayer EA et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrheapredominant irritable bowel syndrome. Arch Intern Med 2001; 161: 1733-40.
24. Chey WD, Chey WY, Heath AT et al. Long-term safety and effi cacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2004; 99: 2195-203.
25. Pimentel M, Lembo A, Chey WD et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. New Engl J Med 2011; 364: 22-32.
26. Lembo AJ, Lacy BE, Zuckerman MJ et al. Eluxadoline for irritable bowel syndrome with diarrhea. New Engl J Med 2016; 374: 242-53.
27. Staudacher HM, Lomer MC, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifi dobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510-8.
28. de Roest RH, Dobbs BR, Chapman BA et al. Th e low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Intern J Clin Pract 2013; 67: 895-903.
29. Willett W. Nutritional epidemiology. Monographs in epidemiology and biostatistics v 40, 3rd ed. Oxford University Press: Oxford, UK, 2013.
30. Block G. A review of validations of dietary assessment methods. Am J Epidemiol 1982; 115: 492-505.
31. Block G, Hartman AM. Issues in reproducibility and validity of dietary studies. Am J Clin Nutr 1989; 50: 1133-8.